Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01100398 · ClinicalTrials.gov registry record
Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Utilizing Ultrasound and Percutaneous Liver Biopsy
A clinical trial of Fatty Liver, sponsored by Brooke Army Medical Center.
- Completed
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT01100398 is a study of Fatty Liver that has completed, run by Brooke Army Medical Center. The registered enrollment target is 400 participants, above the 191-participant average among 20 other Fatty Liver trials with a reported enrollment target (109% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01100398, a study of Fatty Liver, has completed, sponsored by Brooke Army Medical Center.
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective determination of the prevalence of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)in a primary care setting using ultrasound and percutaneous liver biopsy.
Conditions Studied
Interventions
- PROCEDURE possible liver biopsy and serum collection
Study Locations (1)
Texas
- Brooke Army Medical Center - Fort Sam Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2007-01 |
| Est. Completion | 2010-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01100398
The ClinicalTrials.gov registry entry for NCT01100398 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 191-participant average among 20 other Fatty Liver trials with a reported enrollment target (109% higher). The listed sponsor is Brooke Army Medical Center, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Fatty Liver appearing as the primary indexed condition, and to 1 intervention - of which possible liver biopsy and serum collection is the first listed.
NCT01100398 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01100398 about?
NCT01100398 is a clinical study titled "Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Utilizing Ultrasound and Percutaneous Liver Biopsy". Prospective determination of the prevalence of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)in a primary care setting using ultrasound and percutaneous liver biopsy.
What is the current status of trial NCT01100398?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2007-01. Estimated completion is 2010-05.
What conditions does trial NCT01100398 study?
This clinical trial studies the following conditions: Fatty Liver.
What interventions are being tested in trial NCT01100398?
The interventions under investigation include: possible liver biopsy and serum collection (PROCEDURE).
Who is sponsoring clinical trial NCT01100398?
This trial is sponsored by Brooke Army Medical Center, which has 54 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01100398 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fatty Liver
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Intermittent Fasting for NAFLD in Adults
RECRUITING · NA
-
Early Tracking of Childhood Health Determinants (ETCHED) Study
RECRUITING
-
Exploratory Analysis of Enhanced Liver Function (ELF) Test to Detect Early Fatty Liver in High Risk Population
RECRUITING
-
Blood Collection Biorepository for Liver Disease Research
RECRUITING
-
Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis
ACTIVE NOT RECRUITING · Phase 2
-
Liver Positron Emission Tomography (PET) Study of Non Alcoholic Fatty Liver Disease
COMPLETED · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.